Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)||
||Other / NIH / Industry||
||200||All||5 Years and older (Child, Adult, Older Adult)||NCT00106184||N01 AR042273
|March 2006||February 2010||August 2010||March 22, 2005||March 4, 2015||March 4, 2015||